On Tuesday, Reynolds American, Inc. (NYSE:RAI)’s shares inclined 1.51% to $72.13.
Reynolds American, Inc. (RAI) has declared the following: “Reynolds American to acquire Lorillard on June 12, 2015.”
RAI’s website, www.reynoldsamerican.com, is the primary source of publicly revealed news about RAI and its operating companies. We use the website as our primary means of distributing quarterly earnings and other company news. We encourage investors and others to register at www.reynoldsamerican.com to receive alerts when news about the company has been posted.
Reynolds American Inc., through its auxiliaries, manufactures and sells cigarettes and other tobacco products in the United States. It operates through RJR Tobacco, American Snuff, and Santa Fe segments. The RJR Tobacco segment offers cigarettes under the brand names of CAMEL, PALL MALL, WINSTON, KOOL, DORAL, SALEM, MISTY, and CAPRI; and CAMEL Snus, a smoke-free tobacco product, in addition to manages various licensed brands, counting DUNHILL and STATE EXPRESS 555.
MGIC Investment Corp. (NYSE:MTG)’s shares dropped -0.46% to $10.90.
MGIC Investment Corp. (MTG) continued its streak of strong operating statistics, seen over several months, in May 2015. The trend reflects a decline in the delinquency level and an improvement in new business written.
Primary new insurance written for May 2015 was $3.7 billion, up 32% year over year and 2.8% sequentially.
Delinquency loans (loans that failed to pay back) at MGIC Investment witnessed an improvement on a year-over-year basis. Delinquent inventory for the month under review was 68,224, down 21% year over year and 2% sequentially.
Established in 1957, MGIC Investment is the nation’s oldest private mortgage insurer, with insurance in force of $164.9 billion.
The company which was devastated by the 2008 financial crisis is crawling back. Its fortunes have been shored up by declining delinquencies and improving cure rates on claims from its legacy business. The prospects of the company also look bright on its growing book of high-credit-quality business written since 2009.
MGIC Investment Corporation, through its auxiliaries, provides private mortgage insurance and ancillary services to lenders and government sponsored entities in the United States. The company offers primary mortgage insurance that provides mortgage default protection on individual loans, in addition to covers unpaid loan principal, delinquent interest, and various expenses associated with the default and subsequent foreclosure; and pool insurance coverage, which covers the excess of the loss on a defaulted mortgage loan that exceeds the claim payment under the primary coverage.
At the end of Tuesday’s trade, Suncor Energy Inc. (USA) (NYSE:SU)‘s shares surged 2.85% to $29.07.
Suncor Energy Inc. (USA) (SU) is an oil company focused on developing Canada’s petroleum resource basin, Athabasca oil sands.
Oil prices were falling after the U.S. Energy Information Administration said it anticipates shale oil production to fall by 91,000 barrels a day to 5.5 million barrels a day in July when contrast to June production rates, according to the Wall Street Journal.
High shale oil production in the U.S. contributed to the recent record high U.S. oil stockpile levels and assisted bring down oil prices last year.
WTI crude oil for July delivery was up 3.5% to $60.17 a barrel early Tuesday afternoon, and Brent crude oil for July delivery was up 3.7% to $64.98 a barrel.
Suncor Energy Inc. operates as an integrated energy company. The company primarily focuses on developing petroleum resource basins in Canada’s Athabasca oil sands; explores, acquires, develops, produces, and markets crude oil and natural gas in Canada and internationally; transports and refines crude oil; markets petroleum and petrochemical products primarily in Canada; and markets third party petroleum products. It operates in Oil Sands; Exploration and Production; Refining and Marketing; and Corporate, Energy Trading, and Eliminations segments.
Mylan NV (NASDAQ:MYL), ended its Tuesday’s trading session with 0.20% gain, and closed at $73.80.
Mylan NV (MYL) declared the U.S. launch of Guanfacine Extended-release Tablets, 1 mg, 2 mg, 3 mg, and 4 mg, which is the generic version of Shire’s INTUNIV® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications.
Guanfacine Extended-release Tablets, 1 mg, 2 mg, 3 mg, and 4 mg, had U.S. sales of about $804.9 million for the 12 months ending March 31, 2015, according to IMS Health.
Presently, Mylan has 271 ANDAs pending FDA approval representing $106 billion in annual brand sales, according to IMS Health. Forty-seven of these pending ANDAs are potential first-to-file opportunities, representing $32 billion in annual brand sales, for the 12 months ending December 31, 2014, according to IMS Health.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, inject able, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
